|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/51 | (2006.01) |
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 3670528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19211623.4 |
| Date of filing the European patent application | 2006-04-28 | |
| (97) | Date of publication of the European application | 2020-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation | 2021-12-27 |
| (30) | Number | Date | Country code |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 411003 | 2006-04-25 | US |
| (72) |
PASZTY, Christopher , US
ROBINSON, Martyn Kim , GB
GRAHAM, Kevin , US
HENRY, Alistair James , GB
HOFFMAN, Kelly Sue , US
LATHAM, John , US
LAWSON, Alastair , GB
LU, Hsieng Sen , US
POPPLEWELL, Andy , GB
SHEN, Wenyan , US
WINKLER, David , US
WINTERS, Aaron George , US
|
| (73) |
UCB Pharma S.A. ,
Allée de la Recherche 60, 1070 Brussels,
BE
Amgen, Inc , One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sklerostiną surišantys agentai |
| SCLEROSTIN BINDING AGENTS |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 20 | 347.00 EUR |